Literature DB >> 8890160

Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.

R W Hendriks1, M F de Bruijn, A Maas, G M Dingjan, A Karis, F Grosveld.   

Abstract

Bruton's tyrosine kinase (Btk) is a cytoplasmic protein kinase that is defective in X-linked agammaglobulinaemia in man and in X-linked immunodeficiency in the mouse. There is controversy regarding the stages of B cell development that are dependent on Btk function. To determine the point in B cell differentiation at which defects in Btk become apparent, we generated a mouse model by inactivating the Btk gene through an in-frame insertion of a lacZ reporter by homologous recombination in embryonic stem cells. The phenomenon of X-chromosome inactivation in Btk+/- heterozygous female mice enabled us to evaluate the competition between B cell progenitors expressing wild-type Btk and those expressing the Btk-/lacZ allele in each successive step of development. Although Btk was already expressed in pro-B cells, the first selective disadvantage only became apparent at the transition from small pre-B cells to immature B cells in the bone marrow. A second differentiation arrest was found during the maturation from IgD(low)IgM(high) to IgD(high)IgM(low) stages in the periphery. Our results show that Btk expression is essential at two distinct differentiation steps, both past the pre-B cell stage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890160      PMCID: PMC452224     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

2.  B cells from CBA/N mice do not proliferate following ligation of CD40.

Authors:  J Hasbold; G G Klaus
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

3.  Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.

Authors:  M de Weers; R G Mensink; M E Kraakman; R K Schuurman; R W Hendriks
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

4.  The expression of Vpre-B/lambda 5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice.

Authors:  H Karasuyama; A Rolink; Y Shinkai; F Young; F W Alt; F Melchers
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

5.  Tec homology (TH) adjacent to the PH domain.

Authors:  M Vihinen; L Nilsson; C I Smith
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

Review 6.  Bruton's tyrosine kinase is a key regulator in B-cell development.

Authors:  D J Rawlings; O N Witte
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988

7.  Expression of the X-linked agammaglobulinemia gene, btk in B-cell acute lymphoblastic leukemia.

Authors:  F E Katz; R C Lovering; L A Bradley; K P Rigley; D Brown; F Cotter; J M Chessells; R J Levinsky; C Kinnon
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

8.  Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.

Authors:  C I Smith; B Baskin; P Humire-Greiff; J N Zhou; P G Olsson; H S Maniar; P Kjellén; J D Lambris; B Christensson; L Hammarström
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

9.  ER-MP12 antigen, a new cell surface marker on mouse bone marrow cells with thymus-repopulating ability: I. Intrathymic repopulating ability of ER-MP12-positive bone marrow cells.

Authors:  W A Slieker; M F de Rijk-de Bruijn; P J Leenen; W van Ewijk
Journal:  Int Immunol       Date:  1993-09       Impact factor: 4.823

10.  The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver.

Authors:  Y S Li; K Hayakawa; R R Hardy
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  43 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins.

Authors:  Christopher W Chiu; Mark Dalton; Masamichi Ishiai; Tomohiro Kurosaki; Andrew C Chan
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

4.  A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Authors:  Shuling Guo; Gregory Z Ferl; Rajendar Deora; Mireille Riedinger; Sheng Yin; James L Kerwin; Joseph A Loo; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

5.  Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Authors:  Patrick M Meyer Sauteur; Adrianus C J M de Bruijn; Catarina Graça; Anne P Tio-Gillen; Silvia C Estevão; Theo Hoogenboezem; Rudi W Hendriks; Christoph Berger; Bart C Jacobs; Annemarie M C van Rossum; Ruth Huizinga; Wendy W J Unger
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

6.  Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.

Authors:  G M Dingjan; A Maas; M C Nawijn; L Smit; J S Voerman; F Grosveld; R W Hendriks
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

Review 7.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region.

Authors:  D Drabek; S Raguz; T P De Wit; G M Dingjan; H F Savelkoul; F Grosveld; R W Hendriks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

9.  The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.

Authors:  J Hess; P J Nielsen; K D Fischer; H Bujard; T Wirth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

10.  Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies.

Authors:  Sabine Ponader; Jan A Burger
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.